GlaxoSmithKline notifies SEC, DOJ of new questions in China bribery probe
admin 7th February 2018 Uncategorised 0GlaxoSmithKline’s China bribery imbroglio is the scandal that just won’t die. After having paid more than half a billion dollars to lay to rest investigations by Chinese and U.S. authorities, the U.K. drugmaker has now been asked for new info from fraud investigators in its home country.
More: GlaxoSmithKline notifies SEC, DOJ of new questions in China bribery probe
Source: fierce